Hofstetter, G.; Grech, C.; Pils, D.; Pammer, J.; Neudert, B.; Pötsch, N.; Baltzer, P.; Traub-Weidinger, T.; Seebacher, V.; Aust, S.
Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer. J. Pers. Med. 2022, 12, 551.
https://doi.org/10.3390/jpm12040551
AMA Style
Hofstetter G, Grech C, Pils D, Pammer J, Neudert B, Pötsch N, Baltzer P, Traub-Weidinger T, Seebacher V, Aust S.
Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer. Journal of Personalized Medicine. 2022; 12(4):551.
https://doi.org/10.3390/jpm12040551
Chicago/Turabian Style
Hofstetter, Gerda, Christina Grech, Dietmar Pils, Johannes Pammer, Barbara Neudert, Nina Pötsch, Pascal Baltzer, Tatjana Traub-Weidinger, Veronika Seebacher, and Stefanie Aust.
2022. "Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer" Journal of Personalized Medicine 12, no. 4: 551.
https://doi.org/10.3390/jpm12040551
APA Style
Hofstetter, G., Grech, C., Pils, D., Pammer, J., Neudert, B., Pötsch, N., Baltzer, P., Traub-Weidinger, T., Seebacher, V., & Aust, S.
(2022). Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer. Journal of Personalized Medicine, 12(4), 551.
https://doi.org/10.3390/jpm12040551
